Form 4 for OBIO Orchestra BioMed Holdings, Inc.
Accepted 2025-08-25 00:00:00 ET · period of report 2025-08-25 · accession 0001104659-25-082633 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-25 | 2025-08-25 | OBIO | Taylor Andrew Lawrence | CFO | P - Purchase | $2.55 | +2,000 | 482.8K | +0.4% | +$5,100 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share | 2025-08-25 | P | A | 2,000 | $2.55 | 482,788 | D | — | — |